Publications by authors named "Amedeo A Azizi"

Claim this Profile
A
Accelerated Linear Growth during Erdafitinib Treatment: An FGFR-Related, but Growth Factor and Sex Steroid-Independent Mechanism?
Gabriele Hartmann, Adalbert Raimann, Natalia Stepien, Amedeo A Azizi, Gabriele Hartmann

Horm Res Paediatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative epileptiform discharges predict seizure outcomes in pediatric low-grade developmental and epilepsy associated tumors.
Florian Mayer, Johannes Zielke, Birgit Pimpel, Katharina Moser, Clara Köller, Amedeo A Azizi

Clin Neurophysiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medulloblastoma: Current Standard of Care and Future Treatment Opportunities.
Lisa Mayr, Amedeo A Azizi, Johannes Gojo, Andreas Peyrl

Paediatr Drugs· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Seizure Outcome After Epilepsy Surgery in Pediatric Patients With Low-Grade Developmental and Epilepsy-Associated Brain Tumors.
Florian Mayer, Matthias Tomschik, Johannes Zielke, Magdalena Vass, Birgit Pimpel, Amedeo A Azizi

Pediatr Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofibromatosis type 1 adult surveillance form for Austria.
Vincent Sunder-Plassmann, Amedeo A Azizi, Said Farschtschi, Robert Gruber, Markus Hutterer

Wien Klin Wochenschr· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Plastic surgical treatment of neurofibromatosis type 1].
Gregor Längle, Andreas Gohritz, Clemens Gstöttner, Leopold Harnoncourt, Hannes Platzgummer, Amedeo A Azizi

Chirurgie (Heidelb)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective targeting of PDGFRA-altered high-grade glioma with avapritinib.
Lisa Mayr, Sina Neyazi, Kallen Schwark, Maria Trissal, Alexander Beck, Amedeo A Azizi

Cancer Cell· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E Mutation in Ganglioglioma: Impact on Epileptogenicity and Implications for Surgical Strategy.
Matthias Tomschik, Eva Horner, Alexandra Lang, Florian Mayer, Thomas Czech, Amedeo A Azizi

Eur J Neurol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative lengthening of telomere-based immortalization renders H3G34R-mutant diffuse hemispheric glioma hypersensitive to PARP inhibitor combination regimens.
Anna Laemmerer, Christian Lehmann, Lisa Mayr, Katharina Bruckner, Lisa Gabler, Amedeo A Azizi

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas.
Amedeo A Azizi, Darren Hargrave, João Passos, Pierre Wolkenstein, Thorsten Rosenbaum

Neurooncol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The telovelar approach for fourth ventricular tumors in children: is removal of the posterior arch of C1 necessary?
Anna Cho, Maria Aliotti Lippolis, Johannes Herta, Muhammet Dogan, Cora Hedrich, Amedeo A Azizi

Childs Nerv Syst· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance, rebound, and recurrence regrowth patterns in pediatric low-grade glioma treated by MAPK inhibition: A modified Delphi approach to build international consensus-based definitions-International Pediatric Low-Grade Glioma Coalition.
Patricia O'Hare, Tabitha Cooney, Peter de Blank, David H Gutmann, Mark Kieran, Amedeo A Azizi

Neuro Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Britt A E Dhaenens, Günter Heimann, Annette Bakker, Marco Nievo, Rosalie E Ferner, Amedeo A Azizi

Neurooncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors.
Iris K Minichmayr, Ursula Knaack, Johannes Gojo, Daniel Senfter, Christine Haberler, Amedeo A Azizi

Paediatr Drugs· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma.
Cora Hedrich, Priya Patel, Lukas Haider, Tracey Taylor, Elaine Lau, Amedeo A Azizi

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients.
Natalia Stepien, Lisa Mayr, Maria T Schmook, Adalbert Raimann, Christian Dorfer, Amedeo A Azizi

Pediatr Blood Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.
Cornelis M van Tilburg, Lindsay B Kilburn, Sébastien Perreault, Rene Schmidt, Amedeo A Azizi

BMC Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.
Andreas Peyrl, Monika Chocholous, Magnus Sabel, Alvaro Lassaletta, Jaroslav Sterba, Amedeo A Azizi

JAMA Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical applicability of miR517a detection in liquid biopsies of ETMR patients.
Sibylle Madlener, Julia Furtner, Natalia Stepien, Daniel Senfter, Lisa Mayr, Amedeo A Azizi

Acta Neuropathol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapies.
Lisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, Sibylle Madlener, Robert Strassl, Amedeo A Azizi

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapies.
Lisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, Sibylle Madlener, Robert Strassl, Amedeo A Azizi

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutional Microsatellite Instability, Genotype, and Phenotype Correlations in Constitutional Mismatch Repair Deficiency.
Richard Gallon, Rachel Phelps, Christine Hayes, Laurence Brugieres, Léa Guerrini-Rousseau, Amedeo A Azizi

Gastroenterology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof-of-Concept for Liquid Biopsy Disease Monitoring of -Amplified Group 3 Medulloblastoma by Droplet Digital PCR.
Natalia Stepien, Daniel Senfter, Julia Furtner, Christine Haberler, Christian Dorfer, Amedeo A Azizi

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.
Charlotte Carton, D Gareth Evans, Ignacio Blanco, Reinhard E Friedrich, Rosalie E Ferner, Amedeo A Azizi

EClinicalMedicine· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral infections in pediatric brain tumor patients treated with targeted therapies.
Lisa Mayr, Tobias Steinmaurer, Lukas Weseslindtner, Sibylle Madlener, Robert Strassl, Amedeo A Azizi

Pediatr Blood Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis